| Print
Tiziana Life Sciences Ltd (TLSA)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.
Address
11-12 St. James's Square
3rd Floor
London
GBR
SW1Y 4LB
Telephone
+44 2074952379
Forecast key dates
| Name | Key Date |
|---|---|
| Tiziana Life Sciences Ltd Annual General Meeting for 2026 | 2026-12-16T08:30:00 |
| Tiziana Life Sciences Ltd Second Quarter Earnings Results for 2026 | 2026-10-02T00:00:00 |
| Tiziana Life Sciences Ltd Annual Report for 2025 | 2026-05-06T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Tiziana Life Sciences Ltd Annual General Meeting for 2025 | 2025-12-16T08:30:00 |
| Tiziana Life Sciences Ltd Second Quarter Earnings Results for 2025 | 2025-10-03T00:00:00 |
| Tiziana Life Sciences Ltd Annual Report for 2024 | 2025-05-06T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.